* Low <3000₺; intermediate 3000 – 5000 ₺; High >
5000 ₺
T. gondii IgG antibodies were found statistically higher in 63
(53.8%) of the 117 patients with schizophrenia and in 33 (27.5%) of
the 120 controls (p < 0.001). When the cases included in the
schizophrenia group are examined by dividing into two sub-groups
according to their suicide attempt history, the relationship between the
history of suicide attempt and seroprevalence T. gondii was again
found to be statistically significant (p < 0.05). In
reflection of our serological findings, it was determined that the rates
of T. gondii seropositivity were higher in the schizophrenia
group, compared to the control group. Likewise, T. gondii IgG
antibodies positivity was found to be more in schizophrenia patients
with a history of suicide attempt (Table 3).
The results in Table 3 also summarized that the molecular detection ofT. gondii by PCR. The molecular positivity rate of T. gondii was
higher in schizophrenia group, compared to healthy control group (p
< 0.05), whereas history of suicide attempts was not
statistically associated (p = 0.831) with T. gondii positivity by
PCR (Table 3). This could be attributed to the fact that the T.
gondii is less detected by the molecular method than the serological
method. In this study, the amplified products were visualized by the
standard gel electrophoresis and Figure 2 shows a sample image of
electrophoresis.
Table 3. Comparison between schizophrenia and control group forT. gondii status